Engineering the tumor microenvironment: oncolytic NDV to facilitate CAR-T cell therapy
Abstract Chimeric antigen receptor (CAR)-T cell therapy has achieved significant progress in the treatment of hematologic cancers but continues to face major obstacles in solid tumors, including antigen heterogeneity, limited infiltration, and an immunosuppressive tumor microenvironment (TME). Oncol...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2025-11-01
|
| Σειρά: | Journal of Translational Medicine |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s12967-025-07342-0 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|